Benzinga | Nov 5, 2020 04:15PM EST

Ocular Therapeutix Q3 EPS $(0.21) Beats $(0.24) Estimate, Sales $5.90M Beat $5.49M Estimate

Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.21) per share which beat the analyst consensus estimate of $(0.24) by 12.5 percent. This is a 53.33 percent increase over losses of $(0.45) per share from the same period last year. The company reported quarterly sales of $5.90 million which beat the analyst consensus estimate of $5.49 million by 7.47 percent. This is a 611.70 percent increase over sales of $829.00 thousand the same period last year.